Etiology and treatment of epilepsy in the elderly;Etiologija i liječenje epilepsije osoba starije dobi

Acta Medica Croatica

Volumn 59, Issue 1, 2005, Pages 63-67

  Miškov S, Snježana ^a   Roje Bedeković, Marina ^a   Mikula, Ivan ^a   Demarin, Vida ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Antiepileptic drugs; Epilepsy; Etiology; The elderly

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; GABAPENTIN; LAMOTRIGINE; OXAZEPAM; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; AGED; ANTICONVULSANT THERAPY; ARTICLE; AWARENESS; CEREBROVASCULAR DISEASE; DRUG EFFICACY; DRUG PREFERENCE; EPILEPSY; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HUMAN; INJURY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MONOTHERAPY; TONIC CLONIC SEIZURE; TUMOR;

AGED; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; MALE;

EID: 15244342642     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Brodie MJ, Schachter SC. Elderly patients. U: Brodie MJ, Schachter SC. Epilepsy. Oxford: Oxford Health Press, 2001, 59.
2. Browne RT, Holmes G. Special consideration in women and the elderly. U: Handbook of epilepsy. Philadelphia: Lippincott-Williams & Wilkins, 2000, 215-19.
3. Epilepsy in the elderly. U: European White Paper on Epilepsy. Eurocare UCB SA. 2001, 79-80.
4. Brodie MJ, Schachter SC. Elderly patients. U: Faught E. Epidemiology and drug treatment of epilepsy in elderly people. Drug Aging 1999; 15: 255-69.
5. Sander JW. The epidemiology of epilepsy revised. Curr Opin Neurol 2003; 16: 165-70.
6. Mase G i sur. Late epileptic sezures after cerebral ishemic lesions: the role of silent infarctions. Epilepsia 2001; 42: 161-3.
7. Schreiner A i sur. Epileptic seizures in subcortical vascular encephalopathy. J Neurol Sci 1995; 130: 171-7.
8. Hulihan JF. Seizures in special populations. Postgrad Med 1997; 102: 1-13.
9. Faught E. Epidemiology and drug treatment of epilepsy in elderly people. Drug Aging 1999; 15: 255-69.
10. Blume J i sur. Consideration in the management of epilepsy in the elderly. Geriatr Aging 2003; 6: 33-7.
11. Boro A, Haut S. Medical comorbidites in the treatment of epilepsy. Epilepsy Behav 2003; 4: 1-12.
12. Ramsay RE, Pryor E. Epilepsy in the elderly. Neurology 2000; 51: 9-14.
13. Rowan AJ. Reflection on treatment of seizures in the elderly population. Neurology 2000 51: 28-33.
14. Patsalos PN, Perucca E. Clinical important drug interactions in epilepsy: interaction between antiepileptic drugs and other drugs. Lancet Neurol 2003; 2: 473-81.
15. Gil-Nagel A. Review of new anti-epileptic drugs as initial therapy. Epilepsia 2003; 44: 3-10.
16. Battino D i sur. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data. Epilepsia 2003; 44: 944-9.
17. Giorgi L i sur. The tolerability of lamotrigine in elderly patients with epilepsy. Drug Aging 2001; 18: 621-30.
18. Brodie M i sur. Lamotrigine Elderly Study Group. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999; 37: 81-7.
19. Fernandez JHL. Gabapentin: its mechanisms of action in the year 2003. Rev Neurol 2003; 36: 115-19.
20. Mula M i sur. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia 2003; 44: 659-66.
21. Miškov S, Roje Bedeković M, Mikula I, Cović Negovetić R, Demarin V. Etiology and complexity of the therapy-epilepsy in the elderly. Epilepsia 2003; 44: 18.